Navigation Links
AccuVein AV300, First Portable Vein Illumination Device, Now Available on GSA Schedule
Date:6/29/2009

5-Year Contract Makes AccuVein's Device Now Available to Veteran and Military Hospitals

COLD SPRING HARBOR, N.Y., June 29 /PRNewswire/ -- AccuVein LLC today announced a five-year agreement with the U.S. General Services Administration (GSA). This agreement brings the AccuVein AV300, the world's first hand-held, non-contact vein illumination device, to GSA organizations including military and veteran hospitals.

The AccuVein AV300 helps healthcare professionals locate hard-to-find veins. IV starts, blood draws and blood donation (venipuncture) can be a source of patient anxiety and discomfort, and accessing veins in difficult patients can take up to 10 minutes and require multiple needle sticks. Venipuncture is the most common invasive medical procedure with an estimated 2.7 million procedures conducted every day in the United States alone. The AV300 can help reduce the need for multiple needle sticks, with the goal of improving patient care and the time to access veins.

"Adding the AccuVein AV300 on the GSA schedule brings a valuable device to these healthcare professionals at the front-line of patient care, enabling them to see a vein map on the skin to improve the time, comfort and cost of care," said Stephen P. Conlon, President, AccuVein. "We've had strong interest from a broad range of Military, Federal and State medical institutions and the GSA agreement enables greater access to this important advancement in patient care."

Weighing only 10 ounces, the AV300 uses point-and-click technology -- the healthcare professional simply presses a button and positions the device above the patient's skin to display a map on the skin of underlying veins. With a range of hands-free options, the AV300 can quickly switch between a hand-held and hands-free mode, freeing the practitioner's hands to perform the venipuncture.

Government organizations that can purchase the AccuVein AV300 fro
'/>"/>

SOURCE AccuVein LLC
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Video: AccuVein Launches First Portable, Non-Contact Vein Illumination Device
2. Prometheus Launches MyCeliacID(TM), the First Do it Yourself, Saliva-Based Genetic Test Dedicated to Celiac Disease
3. Video: New Online Film Introduces Longevinex Advantage(TM) -- The First Resveratrol-Based Dietary Supplement to Address Both Cellular and Connective Tissue Aging
4. MD Now Urgent Care Centers: First in Florida to Receive UCAOA Certification in Urgent Care
5. Aegis Living Was Created To Place People First in Senior and Assisted Living Communities
6. Team Type 1 Takes First Place Finish in Race Across America
7. Nations first childrens hospital-based safety store focuses on child injury prevention
8. First Day of Summer Has Come: Enjoy the Summer Sunshine Without Putting Yourself at Risk
9. MinuteClinic Becomes Participating Provider in All CareFirst BlueCross BlueShield Plans
10. First Coast Medicare to Provide Case by Case Reimbursement for the Renessa(R) Treatment for Incontinence in Women
11. Cytox Raises Pre-Series A Financing From Management and Existing UK Investors, Welcomes First US Investors

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2009)...more likely to consider change after 30-minute psy...FRIDAY, Nov. 27 (HealthDay News) -- A program that...y should stop their dangerous behavior may lead to... have found. , The new study included 184 men a...onvictions, who were randomly assigned to one of t...
(Date:11/27/2009)..., Nov. 27 /PRNewswire/ - Uploadable USB pedometers... in wellness. A combination of advanced accelerome...lving a long term concern over the accuracy of sel...auge and reward improved participation in a fitnes... the first wellness suppliers to integrate this te...
(Date:11/27/2009)... N.Y., Nov. 27 Preventi...er and fortunately every year, new vaccines are be...all vaccines boost immunity for the same period of...hots, needed to keep immunity strong? ,, In t...e American Academy of Pediatrics, Michael Pichiche...
(Date:11/27/2009)...us low-emission vehicles may reduce future disease.... 27 (HealthDay News) -- Encouraging city dwellers...ffer much greater public health benefits than incr...ers have found. , The study compared the projec...nd transport scenarios for London, England, and De...
(Date:11/27/2009)... Multi-purpose bilingual coloring books designe...he business community to educate - inform parents ...afety issues to Dinosuars to ABC,S and a host of o...s, MO (PRWEB) November 27, 2009 -- Today’s c...o keep them busy any hour of the day, but one of t...
Breaking Medicine News(10 mins):Health News:Drunk Drivers May Respond to Brief Motivational Interview 2Health News:New USB technology adds accountability and convenience to wellness programs 2Health News:Why Some Vaccines May Require A Booster 2Health News:Why Some Vaccines May Require A Booster 3Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2
...ijuana use among teens is slowing, survey finds , ...ile marijuana and alcohol use has declined among t... Oxycontin has increased, a new report shows. , Bu...n its report, Monitoring the Future: National Res...
...Dec. 11 Emerging Growth Equities, Ltd. initiates ...MX) with a BUY rating and a $9.00 price target. P...erapeutic drug products for serious, life-threaten... , Emerging Growth Equities, Ltd., is a special...
...ections are a serious risk of a long-term hospital...a lung infection that develops in about 15% of all...erous. With weakened immune systems and a higher ...hanks to a proven new clinical approach developed ...
...L (Dec. 11, 2008) The University of Minnesota has...ch from the Richard M. Schulze Family Foundation. ..., are to capitalize on the University,s strength i...e second largest in the history of the University ...
...ricans United for Life (AUL) today released its 20...e addition of eight new guides this year, AUL now ...s related to abortion, protection of unborn victim...e leading developer of cutting-edge pro-life legis...
... , , , , , , , ..., , VIDEO: , A new study at Washi...as shown that estrogen therapy can shrink tumors i... , , , , , , , ...
Other Medicine News:Health News:10% of U.S. High School Seniors Use Vicodin 2Health News:10% of U.S. High School Seniors Use Vicodin 3Health News:Emerging Growth Equities, Ltd. Initiates Coverage of PolyMedix Inc. With a Buy Rating and a $9.00 Price Target 2Health News:There's a life-saving medical device sitting on your sink 2Health News:University of Minnesota receives $40 million for type 1 diabetes research 2Health News:University of Minnesota receives $40 million for type 1 diabetes research 3Health News:University of Minnesota receives $40 million for type 1 diabetes research 4Health News:Americans United for Life Releases Eight New Model Legislation & Policy Guides: Twenty-Three Model Legislation & Policy Guides Now Available 2Health News:Estrogen pills can benefit women with metastatic breast cancer 2Health News:Estrogen pills can benefit women with metastatic breast cancer 3Health News:Estrogen pills can benefit women with metastatic breast cancer 4Health News:Estrogen pills can benefit women with metastatic breast cancer 5
(Date:11/25/2009)... , WEST PALM BEACH, Fla., Nov. 25 /PRNewswi...ng impaired Americans, especially the 27 million l...may not be all that happy, says audiologist Cindy ...earUSA (Amex: EAR ), one of America,s largest hea...es have linked hearing loss to stress, frustration...
(Date:11/25/2009)... , HARBIN, China, Nov. 25 /PRNewswir..."China Sky One Medical" or "the Company") (Nasdaq:...l company developing and producing,over-the-counte... today,announced that the Company recently passed ...Pharmaceutical and Biological Products ("ICPBP") e...
(Date:11/25/2009)... , EAST BRUNSWICK, N.J., Nov. 25 /PRNewswi...facturer of direct digital Radiography ( ddR ) sys...n acquired by a private Swiss Investor with a long...ing brand. The acquisition included all assets and...nventory. After 25 years of success and growth Swi...
Breaking Medicine Technology:For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 2For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 3China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 2China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 3Swissray International Announces New Ownership 2Swine Flu Shots May Come Too Late to Stem Fall Outbreak 3A Study 56825 1Swine Flu Shots May Come Too Late to Stem Fall Outbreak 3A Study 56825 2Swine Flu Shots May Come Too Late to Stem Fall Outbreak 3A Study 56825 3PRA International Chairs Session on Post Marketing Safety Issues 56821 1PRA International Chairs Session on Post Marketing Safety Issues 56821 2Income Poverty and Health Insurance Coverage in The United States 3A 2008 56818 1Income Poverty and Health Insurance Coverage in The United States 3A 2008 56818 2Income Poverty and Health Insurance Coverage in The United States 3A 2008 56818 3Income Poverty and Health Insurance Coverage in The United States 3A 2008 56818 4Income Poverty and Health Insurance Coverage in The United States 3A 2008 56818 5Income Poverty and Health Insurance Coverage in The United States 3A 2008 56818 6
...NAPOLIS, Nov. 28 Eli Lilly and Company,(NYSE: L...cation (sNDA) from,the U.S. Food and Drug Administ...the management of chronic pain. Lilly plans to res...dding data from a recently completed positive stud... The decision does not affect duloxetine,s FDA-...
... Expanded to 406 Subjects , , FRANKLIN, Mass....LCSF) announced today that it has received full ap...(FDA) for its U.S. pivotal trial to study the effe...and associated therapy in the prevention of Contra...o approved PLC,s request to expand their investiga...
Other Medicine Technology:Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 2Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 3Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 4PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 2PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 3PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 4
... Laboratories is a national reference laboratory a...earch and development. ARUP offers an extensive te... in clinical and anatomic pathology. Owned by the ...lude more than half of the nation's university tea...
... Laboratories is a national reference laboratory a...earch and development. ARUP offers an extensive te... in clinical and anatomic pathology. Owned by the ...lude more than half of the nation's university tea...
... Laboratories is a national reference laboratory a...earch and development. ARUP offers an extensive te... in clinical and anatomic pathology. Owned by the ...lude more than half of the nation's university tea...
... Laboratories is a national reference laboratory a...earch and development. ARUP offers an extensive te... in clinical and anatomic pathology. Owned by the ...lude more than half of the nation's university tea...
Medicine Products: